Privia Health Group

Privia Health Group, Inc. engages in the provision of healthcare services. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experience, and reward doctors for delivering care both in-person and via its Privia Platform, virtual care settings. The company was founded by Jeffrey Butler on November 7, 2007 and is headquartered in Arlington, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Privia Health Group reports robust Q1 performance and growth outlook

Privia Health Group delivered strong financial performance in Q1 2023, with growth in key metrics and a reaffirmation of guidance.
The company faces challenges in maintaining value-based care penetration and addressing analyst inquiries on market performance.
However, Privia Health's strategic focus on expansion, performance improvement, and shared savings generation presents promising opportunities.
Overall, Privia Health's resilience, growth trajectory, and strategic initiatives position them well for future success in the healthcare industry.

Privia Health Group reports robust Q2 growth and strategic expansion

Privia Health Group's Q2 performance reflects strong financial growth, operational stability, and strategic expansion into new markets and care models.
While facing challenges such as increased AR and market entry costs, the company's focus on value-based care and operational optimization positions it for long-term success.
With a robust leadership team, steady provider retention, and a clear growth strategy, Privia is well-positioned to capitalize on opportunities in value-based care and market expansion.

Privia Health Group excels in Q3, poised for growth

Privia Health Group's Q3 performance reflects robust growth in providers, patients, and financial metrics, underpinning its competitive strength and market positioning.
While facing challenges in maintaining growth rates and managing diverse healthcare segments, Privia's strategic focus on expansion and innovation presents growth opportunities.
With a solid financial foundation, innovative business model, and optimistic outlook, Privia is poised for continued success and value creation in the healthcare industry.

Privia Health Group excels in 2023, eyes growth amid challenges

Privia Health Group's strong financial performance, stable cash position, and strategic focus on growth and profitability position it well for future success.
While facing challenges in managing value-based risk arrangements and revenue declines from renegotiated contracts, Privia is adapting and pursuing growth opportunities.
With a solid patient base, prudent financial management, and a clear growth strategy, Privia is navigating market challenges and aiming for continued success in 2024.

Privia Health Group reports robust Q1 performance and eyes growth

Privia Health Group's Q1 2024 performance reflects strong growth and profitability, supported by a robust balance sheet and strategic focus on primary care-centric networks. While facing challenges from certain market exits, the company is well-positioned to capitalize on opportunities in risk arrangements and program enhancements for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ARLINGTON, Va., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it will participate in the 40th Annual J.P. Morgan Healthcare Conference. The Company's management team will present a business overview as part of a virtual fireside chat on Monday, January 10, 2022, beginning at 3:00 pm ET.

Privia Health to Participate in 40th Annual J.P. Morgan Healthcare Conference

The stock price of Privia Health Group Inc (NASDAQ: PRVA) increased by over 12% during intraday trading today. This is why it happened.

Privia Health (PRVA) Stock: Why It Jumped Today

Privia Health Group, Inc. (PRVA) CEO Shawn Morris on Q3 2021 Results - Earnings Call Transcript

ARLINGTON, Va., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine-month periods ended September 30, 2021.

Privia Health Reports Third Quarter 2021 Financial Results

Expands National Provider Network with more than 430 New Providers in California and Texas Expands National Provider Network with more than 430 New Providers in California and Texas

Privia Health Announces Entry into California and West Texas Markets

ARLINGTON, Va., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for the third quarter ended September 30, 2021 before market open on Monday, November 8, 2021.

Privia Health to Report Third Quarter 2021 Results on Monday, November 8

BOSTON--(BUSINESS WIRE)--Privia Health Uses Kyruus' Digital Patient Access Platform to Help Empower Consumers and Drive Practice Growth

Privia Health Uses Kyruus' Digital Patient Access Platform to Help Empower Consumers and Drive Practice Growth

IRVING, Texas--(BUSINESS WIRE)--Biote Medical, a hormone optimization company that provides evidence-based therapeutic solutions to treat hormone imbalances in women and men, today announced the appointments of Dr. Mark Cone and Dana Jacoby to the company's Board of Directors. Cone and Jacoby bring six decades of combined experience in healthcare practice and business leadership to the company's Board. “The appointments of Dr. Cone and Dana Jacoby will support Biote's continued growth as we sca

Biote Medical Announces Appointments Board of Directors

Performance Across All Markets in 2020 Demonstrates Improved Care and Lower System Costs$86.5 Million in Shared Savings Delivered across Georgia, Maryland, Texas, Virginia and Washington, DC

Privia Health Reports Results in CMS' Medicare Shared Savings Program (MSSP)

Privia Health Group, Inc. (PRVA) CEO Shawn Morris on Q2 2021 Results - Earnings Call Transcript

ARLINGTON, Va., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six-month periods ended June 30, 2021.

Privia Health Reports Second Quarter 2021 Financial Results

ARLINGTON, Va., July 22, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for the second quarter ended June 30, 2021 before market open on Monday, August 9, 2021.

Privia Health to Report Second Quarter 2021 Results on Monday, August 9th

Health Catalyst Inc

SOC Telemed

NEW YORK, July 19, 2021 /PRNewswire/ -- Health Enterprise Partners ("HEP"), a healthcare private equity firm, is pleased to announce five realizations of existing portfolio companies, and a new investment in Kno2, the tenth platform investment out of HEP III. Following a tradition of backing founder-financed businesses, HEP's investment came as part of the first source of institutional capital raised by each of these six companies.

HEP Announces Five Realizations and New Investment

ARLINGTON, Va., June 30, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that Jaewon Ryu, MD, JD, has been named to the Company's Board of Directors, effective immediately. In connection with this election, the size of the Board was increased to nine directors.

Dr. Jaewon Ryu Joins Privia Health's Board of Directors

ARLINGTON, Va., June 21, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), a technology-driven, national physician enablement company that collaborates with medical groups, health plans and health systems, today announced that it is set to join the Russell 2000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, 2021.

Privia Health to be Added to Russell 2000 Index

Privia Health Group, Inc. (PRVA) CEO Shawn Morris on Q1 2021 Results - Earnings Call Transcript

ARLINGTON, Va., May 27, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), a technology-driven, national physician enablement company that collaborates with medical groups, health plans and health systems, today announced financial results for the first quarter ended March 31, 2021.

Privia Health Reports First Quarter 2021 Financial Results

ARLINGTON, Va., May 11, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for the first quarter ended March 31, 2021 after market close on Thursday, May 27, 2021.

Privia Health to Report First Quarter 2021 Results on Thursday, May 27th

ARLINGTON, Va.--(BUSINESS WIRE)--Privia Health Group, Inc. (“Privia Health”) (Nasdaq: PRVA), a technology-driven, national physician enablement company that collaborates with medical groups, health plans and health systems, announced the closing of its initial public offering of 22,425,000 shares of its common stock at a public offering price of $23.00 per share. The offering consisted of 5,725,000 shares of common stock offered by Privia Health and 16,700,000 shares of common stock sold by Pri

Privia Health Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Privia Health had its IPO last week on the Nasdaq. CEO Shawn Morris joins us to discuss why physicians are the people to change healthcare.

Disrupting Healthcare - IPO Interview With Privia Health CEO Shawn Morris (Video)

Privia Health Group has seen a successful public offering. Shares have nearly doubled compared to the preliminary offering range as investors like the disruptive business model, but the actual sales growth is not that disruptive.

Privia Health Group: Good Intentions Do Not Automatically Make A Good Investment

ARLINGTON, Va.--(BUSINESS WIRE)--Privia Health Announces Pricing of Initial Public Offering

Privia Health Announces Pricing of Initial Public Offering

Aveanna Healthcare Holdings

Endeavor Group Holdings

FTC Solar

So far in 2021 there have been quite a few appealing Initial Public Offerings (IPOs) available on the stock market . Here are some upcoming IPOs that investors should be watching this week.

Let's Take a Look At Some Upcoming IPOs This Week 4/26

This week's IPO calendar has several offerings on the docket. Many of the names are unfamiliar to most investors but are in areas that could see growth.

News for Privia Health Group Stock (PRVA)